Credit: FILE - In this Wednesday, Oct. 7, 2020, file photo, a vial of the Phase 3 Novavax coronavirus vaccine is seen ready for use in the trial at St. George's University hospital in London. Novavax says its vaccine appears effective against COVID-19 in a large study, including against variants. Results from the study in the U.S. and Mexico were released on Monday, June 14, 2021. (AP Photo/Alastair Grant, File)

Gaithersburg’s Novavax will sell 200 million COVID-19 vaccine doses to Europe

Hogan: ‘We’re not talking about’ bringing back statewide mask mandate

Spreading conspiracy theories gets BSO flutist fired

FEMA covers COVID-death funeral costs — here’s how to apply

Governors aim to reduce racial disparities in traffic enforcement, safety

Bowser slams reports she went maskless indoors: ‘If you want to report on the right-wing wingnuts, have at it’